Correction: Extracellular matrix/integrin signaling promotes resistance to combined inhibition of HER2 and PI3K in HER2                         þ                          breast cancer (Cancer Research (2017) 77 (3280–3292) DOI: 10.1158/0008-5472.CAN-16-2808)

Ariella B. Hanker; Mónica Valeria Estrada; Giampaolo Bianchini; Preston D. Moore; Junfei Zhao; Feixiong Cheng; James P. Koch; Luca Gianni; Darren R. Tyson; Violeta Sánchez; Brent N. Rexer; Melinda E. Sanders; Zhongming Zhao; Thomas P. Stricker; Carlos L. Arteaga

doi:10.1158/0008-5472.CAN-18-4085

Correction: Extracellular matrix/integrin signaling promotes resistance to combined inhibition of HER2 and PI3K in HER2 ^þ breast cancer (Cancer Research (2017) 77 (3280–3292) DOI: 10.1158/0008-5472.CAN-16-2808)

Ariella B. Hanker, Mónica Valeria Estrada, Giampaolo Bianchini, Preston D. Moore, Junfei Zhao, Feixiong Cheng, James P. Koch, Luca Gianni, Darren R. Tyson, Violeta Sánchez, Brent N. Rexer, Melinda E. Sanders, Zhongming Zhao, Thomas P. Stricker, Carlos L. Arteaga

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Abstract

In the original version of this article (1), the stated disclosure of the author Carlos L. Arteaga is incorrect. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

Original language	English (US)
Pages (from-to)	873
Number of pages	1
Journal	Cancer research
Volume	79
Issue number	4
DOIs	https://doi.org/10.1158/0008-5472.CAN-18-4085
State	Published - Feb 15 2019

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1158/0008-5472.CAN-18-4085

Fingerprint

Dive into the research topics of 'Correction: Extracellular matrix/integrin signaling promotes resistance to combined inhibition of HER2 and PI3K in HER2 ^þ breast cancer (Cancer Research (2017) 77 (3280–3292) DOI: 10.1158/0008-5472.CAN-16-2808)'. Together they form a unique fingerprint.

Cite this

Hanker, A. B., Estrada, M. V., Bianchini, G., Moore, P. D., Zhao, J., Cheng, F., Koch, J. P., Gianni, L., Tyson, D. R., Sánchez, V., Rexer, B. N., Sanders, M. E., Zhao, Z., Stricker, T. P., & Arteaga, C. L. (2019). Correction: Extracellular matrix/integrin signaling promotes resistance to combined inhibition of HER2 and PI3K in HER2 ^þ breast cancer (Cancer Research (2017) 77 (3280–3292) DOI: 10.1158/0008-5472.CAN-16-2808). Cancer research, 79(4), 873. https://doi.org/10.1158/0008-5472.CAN-18-4085

Correction: Extracellular matrix/integrin signaling promotes resistance to combined inhibition of HER2 and PI3K in HER2 ^þ breast cancer (Cancer Research (2017) 77 (3280–3292) DOI: 10.1158/0008-5472.CAN-16-2808). / Hanker, Ariella B.; Estrada, Mónica Valeria; Bianchini, Giampaolo et al.
In: Cancer research, Vol. 79, No. 4, 15.02.2019, p. 873.

Research output: Contribution to journal › Comment/debate › peer-review

Hanker, AB, Estrada, MV, Bianchini, G, Moore, PD, Zhao, J, Cheng, F, Koch, JP, Gianni, L, Tyson, DR, Sánchez, V, Rexer, BN, Sanders, ME, Zhao, Z, Stricker, TP & Arteaga, CL 2019, 'Correction: Extracellular matrix/integrin signaling promotes resistance to combined inhibition of HER2 and PI3K in HER2 ^þ breast cancer (Cancer Research (2017) 77 (3280–3292) DOI: 10.1158/0008-5472.CAN-16-2808)', Cancer research, vol. 79, no. 4, pp. 873. https://doi.org/10.1158/0008-5472.CAN-18-4085

Hanker AB, Estrada MV, Bianchini G, Moore PD, Zhao J, Cheng F et al. Correction: Extracellular matrix/integrin signaling promotes resistance to combined inhibition of HER2 and PI3K in HER2 ^þ breast cancer (Cancer Research (2017) 77 (3280–3292) DOI: 10.1158/0008-5472.CAN-16-2808). Cancer research. 2019 Feb 15;79(4):873. doi: 10.1158/0008-5472.CAN-18-4085

Hanker, Ariella B. ; Estrada, Mónica Valeria ; Bianchini, Giampaolo et al. / Correction : Extracellular matrix/integrin signaling promotes resistance to combined inhibition of HER2 and PI3K in HER2 ^þ breast cancer (Cancer Research (2017) 77 (3280–3292) DOI: 10.1158/0008-5472.CAN-16-2808). In: Cancer research. 2019 ; Vol. 79, No. 4. pp. 873.

@article{1191eace849a42edbd6ba948a00b49b6,

title = "Correction: Extracellular matrix/integrin signaling promotes resistance to combined inhibition of HER2 and PI3K in HER2 {\th} breast cancer (Cancer Research (2017) 77 (3280–3292) DOI: 10.1158/0008-5472.CAN-16-2808)",

abstract = "In the original version of this article (1), the stated disclosure of the author Carlos L. Arteaga is incorrect. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.",

author = "Hanker, {Ariella B.} and Estrada, {M{\'o}nica Valeria} and Giampaolo Bianchini and Moore, {Preston D.} and Junfei Zhao and Feixiong Cheng and Koch, {James P.} and Luca Gianni and Tyson, {Darren R.} and Violeta S{\'a}nchez and Rexer, {Brent N.} and Sanders, {Melinda E.} and Zhongming Zhao and Stricker, {Thomas P.} and Arteaga, {Carlos L.}",

note = "Publisher Copyright: {\textcopyright} 2019 American Association for Cancer Research.",

year = "2019",

month = feb,

day = "15",

doi = "10.1158/0008-5472.CAN-18-4085",

language = "English (US)",

volume = "79",

pages = "873",

journal = "Cancer Research",

issn = "0008-5472",

number = "4",

}

TY - JOUR

T1 - Correction

T2 - Extracellular matrix/integrin signaling promotes resistance to combined inhibition of HER2 and PI3K in HER2 þ breast cancer (Cancer Research (2017) 77 (3280–3292) DOI: 10.1158/0008-5472.CAN-16-2808)

AU - Hanker, Ariella B.

AU - Estrada, Mónica Valeria

AU - Bianchini, Giampaolo

AU - Moore, Preston D.

AU - Zhao, Junfei

AU - Cheng, Feixiong

AU - Koch, James P.

AU - Gianni, Luca

AU - Tyson, Darren R.

AU - Sánchez, Violeta

AU - Rexer, Brent N.

AU - Sanders, Melinda E.

AU - Zhao, Zhongming

AU - Stricker, Thomas P.

AU - Arteaga, Carlos L.

PY - 2019/2/15

Y1 - 2019/2/15

N2 - In the original version of this article (1), the stated disclosure of the author Carlos L. Arteaga is incorrect. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

AB - In the original version of this article (1), the stated disclosure of the author Carlos L. Arteaga is incorrect. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

UR - http://www.scopus.com/inward/record.url?scp=85061573193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061573193&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-18-4085

DO - 10.1158/0008-5472.CAN-18-4085

M3 - Comment/debate

C2 - 30770368

AN - SCOPUS:85061573193

SN - 0008-5472

VL - 79

SP - 873

JO - Cancer Research

JF - Cancer Research

IS - 4

ER -

Correction: Extracellular matrix/integrin signaling promotes resistance to combined inhibition of HER2 and PI3K in HER2 þ breast cancer (Cancer Research (2017) 77 (3280–3292) DOI: 10.1158/0008-5472.CAN-16-2808)